Life Changing Daily Pill that Fights Cancer and Autoimmune Diseases

Invest Now for a Limited Time

Trethera News

Gloved hand of a scientist in a lab writing on a digital stilus with a digital pen.

Blue DNA illustration

Photo of a series of test tubes.

Scientific microscope with visual representation of DNA helix

Trethera Announces Prostate Cancer Poster Presentation At The American Association For Cancer Research Annual Meeting

Safety Review Committee Advances Trethera Phase 1 Solid Tumors Trial to Next Dose After First Patient Cohort Achieves Primary Endpoint

December 9, 2021

Trethera Announces FDA Orphan Drug Designation Granted to TRE-515 for the Treatment of Demyelinating Optic Neuritis

November 12, 2021

Trethera Doses First Patient in Landmark Clinical Trial for the Treatment of Solid Tumors With First-In-Class Drug TRE-515

October 15, 2021

Globally Recognized Multiple Sclerosis Expert, Dr. Lawrence “Larry” Steinman, Joins Trethera Scientific Advisory Board